International Clinical Trial: A Multicenter, Prospective, Real-World Study on the Efficacy and Safety of Guselkumab in the Treatment of Inflammatory Bowel Disease

Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133921) titled 'A Multicenter, Prospective, Real-World Study on the Efficacy and Safety of Guselkumab in the Treatment of Inflammatory Bowel Disease' on Oct. 9.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

Condition: Inflammatory Bowel Disease (IBD), including Crohn's Disease (CD) and Ulcerative Colitis (UC).

Intervention: Crohn's disease group:None

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-02-12

Target Sample Size: Crohn's disease group:100;Ulcerative colitis group:100;

Countries of Re...